Sales & Marketing
UK launch market lobbying

Is the UK an attractive launch market?

Leela Barham tries to cut through the lobbying to identify objective measures of the attractiveness of the UK market for launching new medicines. 

Sales & Marketing

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Patients

Patients
Anatomical graphic concept of a liver in 3D

Rewriting the MASLD playbook

Effective care now requires identifying metabolic risks early and addressing the broader factors driving liver damage.

R&D